Literatur
-
1 Carcio H N, Carcio H A eds. Management of the infertile woman. Philadelphia; Lippincott-Raven Publishers 1998
-
2 Jahresbericht 2007, Deutsches IVF-Register (2008). www.meb.uni-bonn.de/frauen/DIR_downloads/dirjahrbuch2007.pdf
-
3
Saravelos S H, Cocksedge K A, Li T C.
Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal.
Hum Reprod Update.
2008;
14
415-429
-
4
Ragni G, Diaferia D, Vegetti W, Colombo M, Arnoldi M, Crosignani P G.
Effectiveness of sonohysterography in infertile patient work-up: a comparison with transvaginal ultrasonography and hysteroscopy.
Gynecol Obstet Invest.
2005;
59
184-188
-
5
Bartkowiak R, Kaminski P, Wielgos M, Bobrowska K.
The evaluation of uterine cavity with saline infusion sonohysterography and hysteroscopy in infertile patients.
Neuro Endocrinol Lett.
2006;
27
523-528
-
6
Cepni I, Ocal P, Erkan S, Saricali F S, Akbas H, Demirkiran F, Idil M, Bese T.
Comparison of transvaginal sonography, saline infusion sonography and hysteroscopy in the evaluation of uterine cavity pathologies.
Aust N Z J Obstet Gynaecol.
2005;
45
30-35
-
7
Kupesic S, Kurjak A, Skenderovic S, Gjelos D.
Screening for uterine abnormalities by three-dimensional ultrasound improves perinatal outcome.
J Perinat Med.
2002;
30
9-17
-
8
Hartman A, Hartman J, Hartman M, Streiner D L, Tur-Kapsa I.
Sonohysterography vs. 3D ultrasound for the diagnosis of uterine anomalies: a prospective blinded study of 500 consecutive women.
Hum Reprod.
2004;
19 (Suppl. 1)
i42
-
9
Kupesic S, Plavsic B M.
2D and 3D hysterosalpingo-contrast-sonography in the assessment of uterine cavity and tubal patency.
Eur J Obstet Gynecol Reprod Biol.
2007;
133
64-69
-
10
Knopman J, Copperman A B.
Value of 3D ultrasound in the management of suspected Asherman's syndrome.
J Reprod Med.
2007;
52
1016-1022
-
11
Watrelot A, Hamilton J, Grudzinskas J G.
Advances in the assessment of the uterus and fallopian tube function.
Best Pract Res Clin Obstet Gynaecol.
2003;
17
187-209
-
12
Oppelt P, Renner S P, Brucker S, Strissel P L, Strick R, Oppelt P G, Doerr H G, Schott G E, Hucke J, Wallwiener D, Beckmann M W.
The VCUAM (Vagina Cervix Uterus Adnex-associated Malformation) classification: a new classification for genital malformations.
Fertil Steril.
2005;
84
1493-1497
-
13
Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons .
Myomas and reproductive function.
Fertil Steril.
2008;
90 (Suppl. 5)
S125-S130
-
14
Divakar H.
Asymptomatic uterine fibroids.
Best Pract Res Clin Obstet Gynaecol.
2008;
22
643-654
-
15
Pérez-Medina T, Bajo-Arenas J, Salazar F, Redondo T, Sanfrutos L, Alvarez P, Engels V.
Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomised study.
Hum Reprod.
2005;
20
1632-1635
-
16
Exacoustos C, Zupi E, Carusotti C, Lanzi G, Marconi D, Arduini D.
Hysterosalpingo-contrast sonography compared with hysterosalpingography and laparoscopic dye pertubation to evaluate tubal patency.
J Am Assoc Gynecol Laparosc.
2003;
10
367-372
-
17
Lanzani C, Savasi V, Leone F P, Ratti M, Ferrazzi E.
Two-dimensional HyCoSy with contrast tuned imaging technology and a second-generation contrast media for the assessment of tubal patency in an infertility program.
Fertil Steril.
2008;
DOI: 10.1016/j.fertnstert.2008.07.1746
-
18
Watrelot A, Hamilton J, Grudzinskas J G.
Advances in the assessment of the uterus and fallopian tube function.
Best Pract Res Clin Obstet Gynaecol.
2003;
17
187-209
-
19
Chan C C, Ng E H, Tang O S, Chan K K, Ho P C.
Comparison of three-dimensional hysterosalpingo-contrast-sonography and diagnostic laparoscopy with chromopertubation in the assessment of tubal patency for the investigation of subfertility.
Acta Obstet Gynecol Scand.
2005;
84
909-913
-
20
Kiyokawa K, Masuda H, Fuyuki T, Koseki M, Uchida N, Fukuda T, Amemiya K, Shouka K, Suzuki K.
Three-dimensional hysterosalpingo-contrast sonography (3D-HyCoSy) as an outpatient procedure to assess infertile women: a pilot study.
Ultrasound Obstet Gynecol.
2000;
16
648-654
-
21
Holz K, Becker R, Schürmann R.
Ultrasound in the investigation of tubal patency. A meta-analysis of three comparative studies of Echovist-200 including 1007 women.
Zentralbl Gynakol.
1997;
119
366-373
-
22
Ekerhovd E, Fried G, Granberg S.
An ultrasound-based approach to the assessment of infertility, including the evaluation of tubal patency.
Best Pract Res Clin Obstet Gynaecol.
2004;
18
13-28
-
23
Venter P F, Iturralde M.
Migration of a particulate radioactive tracer from the vagina to the peritoneal cavity and ovaries.
S Afr Med J.
1979;
55
917-919
-
24
Becker W, Steck T, Albert P, Börner W.
Hysterosalpingoscintigraphy: a simple and accurate method of evaluating fallopian tube patency.
Nuklearmedizin.
1988;
27
252-257
-
25
Steck T, Würfel W, Becker W, Albert P J.
Serial scintigraphic imaging for visualization of passive transport processes in the human fallopian tube.
Hum Reprod.
1991;
6
1186-1991
-
26
Kissler S, Wildt L, Schmiedehausen K, Kohl J, Mueller A, Rody A, Ahr A, Kuwert T, Kaufmann M, Siebzehnruebl E.
Predictive value of impaired uterine transport function assessed by negative hysterosalpingoscintigraphy (HSSG).
Eur J Obstet Gynecol Reprod Biol.
2004;
113
204-208
-
27
Stricker R, Echenard M, Eberhart R, Chevailler M C, Perez V, Quinn F A, Stricker R.
Evaluation of maternal thyroid function during pregnancy: the importance of using gestational age-specific reference intervals.
Eur J Endocrinol.
2007;
157
509-514
-
28
Alexander E K, Marqusee E, Lawrence J, Jarolim P, Fischer G A, Larsen P R.
Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism.
N Engl J Med.
2004;
351
241-249
-
29
Arafah B M.
Increased need for thyroxine in women with hypothyroidism during estrogen therapy.
N Engl J Med.
2001;
344
1743-1749
-
30
Larson J, Anderson E H, Koslawy M.
Thyroid disease: a review for primary care.
J Am Acad Nurse Pract.
2000;
12
226-232
-
31
Demers L M, Spencer C A.
Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease.
Clin Endocrinol (Oxf).
2003;
58
138-140
-
32
Baloch Z, Carayon P, Conte-Devolx B Guidelines Committee, National Academy of Clinical Biochemistry et al.
Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.
Thyroid.
2003;
13
3-126
-
33
Völzke H, Lüdemann J, Robinson D M et al.
The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area.
Thyroid.
2003;
13
803-810
-
34
Brabant G, Beck-Peccoz P, Jarzab B et al.
Is there a need to redefine the upper normal limit of TSH?.
European Journal of Endocrinology.
2006;
154
633-637
-
35
Schultheiss D.
Diagnostik der männlichen Infertilität.
Urologe.
2005;
44
1139-1146
-
36 WHO .WHO-Laborhandbuch zur Untersuchung des menschlichen Ejakulates und der Spermien-Zervikalschleim-Interaktion. Berlin, Heidelberg, New York; Springer Verlag 1999
-
37 Schill W-B. Fertilitätsstörungen des Mannes – Diagnostik und Therapie. Runnebaum B, Rabe T Gynäkologische Endokrinologie und Fortpflanzungsmedizin. Bd. 2 Fortpflanzungsmedizin. Berlin, Heidelberg, New York; Springer-Verlag 1994: 287-336
-
38
Keck C, Denschlag D.
Andrologische Diagnostik bei unerfülltem Kinderwunsch.
Gynäkologe.
2001;
34
953-964
-
39
Haidl G.
Medikamentöse Therapiemöglichkeiten bei männlichen Fertilitätsstörungen.
Urologe (A).
2003;
42
1621-1630
-
40
Practice Committee of American Society for Reproductive Medicine in collaboration with.
Evaluation of the azoospermic male.
Fertil Steril.
2008;
90 (Suppl. 5)
S74-S77
-
41
Practice Committee of American Society for Reproductive Medicine .
Genetic considerations related to intracytoplasmic sperm injection (ICSI).
Fertil Steril.
2008;
90 (Suppl. 5)
S182-S184
-
42 Meken J, Larsen V. Fertility rates and aging. Mastroinanni Jr. L, Paulsen CA Aging, reproduction and the climacteric. New York; Plenum 1986: 147
-
43
Frazier L M, Grainger D A, Schieve L A, Toner J P.
Follicle-stimulating hormone and estradiol levels indepnendently predict the success of assisted reproductive technology treatment.
Fertil Steril.
2004;
82
834-840
-
44
Feyereisen E, Mendez Lozano D H, Taieb J, Hesters L, Frydman R, Fanchin R.
Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status.
Reprod Biomed Online.
2006;
12
695-703
-
45
Popovic-Todorovic B, Loft A, Lindhard A, Bangsbøll S, Andersson A M, Andersen A N.
A prospective study of predictive factors of ovarian response in ‘standard IVF/ICSI patients treated with recombinant FSH. A suggestion for a recombinant FSH dosage normogram.
Hum Reprod.
2003;
18
781-787
-
46
Barad D H, Weghofer A, Gleicher N.
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.
Fertil Steril.
2009;
DOI: 10.1016/j.fertnstert.2008.09.069
-
47
Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N.
A prospective, comparative analysis of anti-Müllerian hormone, inhibine-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
Fertil Steril.
2008;
DOI: 10.1016/j.fertnstert.2008.10.042
-
48
Knauff E A, Eijkemans M J, Lambalk C B, Ten Kate-Booij M J, Hoek A, Beerendonk C C, Laven J S, Goverde A J, Broekmans F J, Themmen A P, de Jong F H, Fauser B C Dutch Premature Ovarian Failure Consortium on behalf of the .
Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
J Clin Endocrinol Metab.
2009;
94
786-792
-
49
Nardo L G, Gelbaya T A, Wilkinson H, Roberts S A, Yates A, Pemberton P, Laing I.
Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Fertil Steril.
2008;
DOI: 10.1016/j.fertnstert.2008.08.127
-
50
Tehrani F R, Solaymani-Dodaran M, Azizi F.
A single test of antimüllerian hormone in late reproductive- aged women is a good predictor of menopause.
Menopause.
2009;
, [Epub ahead of print]
-
51 Sütterlin S, Hoßmann I. www.berlin-institut.org/studien/ungewollt_kinderlos.html
-
52
Beckmann M W, Binder H, Dittrich R et al.
Fertility preservations of patients at risk in german reproductive university centres – a concept paper.
Geburtsh Frauenheilk.
2006;
66
241-251
-
53
Binder H, Dittrich R, Müller A, Cupisti S, Beckmann M W.
Fertilitätserhaltung bei onkologischen Therapien.
Geburtsh und Frauenheilk.
2006;
66
199-226
-
54
Lamar C A, DeCherney A H.
Fertility preservation: state of the science and future research directions.
Fertil Steril.
2009;
91
316-319
-
55
Dittrich R, Mueller A, Binder H, Oppelt P G, Renner S, Goecke T, Hoffmann I, Beckmann M W.
Retransplantation von kryokonserviertem ovariellen Gewebe [First retransplantation of cryopreserved ovarian tissue following cancer therapy in Germany].
Dtsch Arztebl.
2008;
105
274-278
-
56
Mueller A, Oppelt P G, Renner S P, Hoffmann I, Beckmann M W, Dittrich R.
Erste Retransplantation von kryokonserviertem Ovargewebe nach Krebserkrankung in Deutschland mit anschließender Eizellgewinnung und ICSI-Behandlung.
Geburtsh Frauenheilk.
2009;
69
124-130
PD Dr. med. Andreas Müller
Frauenklinik, Universitätsklinikum Erlangen
Universitätsstraße 21–23
91054 Erlangen
Email: andreas.mueller@uk-erlangen.de
